Translational Oncogenomics

Not yet evaluated

About the journal

Translational Oncogenomics is a journal in New Zealand. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

ISSN
1177-2727
Country
New Zealand
Access
Not open access / not declared

Index listings

  • PUBMED · 2008-02-10
Indexing
PUBMED
APC
—
Declared review time (DOAJ)
—
Activity (OpenAlex)
Dormant — no works recorded since 2018
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

22

Last recorded publication year

2018

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

12

i10-index

15

From OpenAlex open data (CC0).

Editorial & policy3
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Open references deposited at Crossref
0%
ORCID iDs in current deposits
0%
Identity & continuity1
Source type
journal
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Epigenetics and DNA Methylation
  • Cancer, Hypoxia, and Metabolism
  • PI3K/AKT/mTOR signaling in cancer
  • Metabolism, Diabetes, and Cancer
  • Hedgehog Signaling Pathway Studies
  • Protein Degradation and Inhibitors
Show all subjects (50)
  • Histone Deacetylase Inhibitors Research
  • MicroRNA in disease regulation
  • Chronic Lymphocytic Leukemia Research
  • Adipose Tissue and Metabolism
  • Protein Degradation and Inhibitors
  • Hedgehog Signaling Pathway Studies
  • Histone Deacetylase Inhibitors Research
  • Metabolism, Diabetes, and Cancer
  • PI3K/AKT/mTOR signaling in cancer
  • Cancer, Hypoxia, and Metabolism
  • Epigenetics and DNA Methylation
  • MicroRNA in disease regulation
  • Chronic Lymphocytic Leukemia Research
  • Adipose Tissue and Metabolism
  • Endometrial and Cervical Cancer Treatments
  • Lymphoma Diagnosis and Treatment
  • Adipokines, Inflammation, and Metabolic Diseases
  • DNA Repair Mechanisms
  • RNA Research and Splicing
  • Genomics and Chromatin Dynamics
  • DNA Repair Mechanisms
  • Hemoglobinopathies and Related Disorders
  • Ovarian cancer diagnosis and treatment
  • Adipokines, Inflammation, and Metabolic Diseases
  • Endometrial and Cervical Cancer Treatments
  • Iron Metabolism and Disorders
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • RNA and protein synthesis mechanisms
  • Genomics and Chromatin Dynamics
  • Mitochondrial Function and Pathology
  • Carcinogens and Genotoxicity Assessment
  • RNA and protein synthesis mechanisms
  • RNA Research and Splicing
  • Carcinogens and Genotoxicity Assessment
  • Ovarian cancer diagnosis and treatment
  • Mitochondrial Function and Pathology
  • Acute Myeloid Leukemia Research
  • Hemoglobinopathies and Related Disorders
  • Iron Metabolism and Disorders
  • Hepatocellular Carcinoma Treatment and Prognosis

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: